These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 30152756)
1. Kasugamycin potentiates rifampicin and limits emergence of resistance in Chaudhuri S; Li L; Zimmerman M; Chen Y; Chen YX; Toosky MN; Gardner M; Pan M; Li YY; Kawaji Q; Zhu JH; Su HW; Martinot AJ; Rubin EJ; Dartois VA; Javid B Elife; 2018 Aug; 7():. PubMed ID: 30152756 [TBL] [Abstract][Full Text] [Related]
2. The essential mycobacterial amidotransferase GatCAB is a modulator of specific translational fidelity. Su HW; Zhu JH; Li H; Cai RJ; Ealand C; Wang X; Chen YX; Kayani MU; Zhu TF; Moradigaravand D; Huang H; Kana BD; Javid B Nat Microbiol; 2016 Aug; 1(11):16147. PubMed ID: 27564922 [TBL] [Abstract][Full Text] [Related]
3. Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems. Chen YX; Pan M; Chen YM; Javid B J Vis Exp; 2019 Apr; (146):. PubMed ID: 31081825 [TBL] [Abstract][Full Text] [Related]
4. Clinically Relevant Mutations of Mycobacterial GatCAB Inform Regulation of Translational Fidelity. Li YY; Cai RJ; Yang JY; Hendrickson TL; Xiang Y; Javid B mBio; 2021 Aug; 12(4):e0110021. PubMed ID: 34225495 [TBL] [Abstract][Full Text] [Related]
5. LipF increases rifampicin and streptomycin sensitivity in a Mycobacterium tuberculosis surrogate. Arriaga-Guerrero AL; Hernández-Luna CE; Rigal-Leal J; Robles-González RJ; González-Escalante LA; Silva-Ramírez B; Mercado-Hernández R; Vargas-Villarreal J; Bermúdez de León M; Peñuelas-Urquides K BMC Microbiol; 2020 May; 20(1):132. PubMed ID: 32450809 [TBL] [Abstract][Full Text] [Related]
6. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice. Vilchèze C; Kim J; Jacobs WR Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757 [TBL] [Abstract][Full Text] [Related]
7. Forward Genetics Reveals a Cai RJ; Su HW; Li YY; Javid B Front Microbiol; 2020; 11():577756. PubMed ID: 33072044 [TBL] [Abstract][Full Text] [Related]
8. GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun. Zhang MJ; Ren WZ; Sun XJ; Liu Y; Liu KW; Ji ZH; Gao W; Yuan B BMC Infect Dis; 2018 May; 18(1):234. PubMed ID: 29788948 [TBL] [Abstract][Full Text] [Related]
9. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya. Elghoul MT; Joshi RM; Rizghalla T Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates. Kisa O; Albay A; Bedir O; Baylan O; Doganci L Int J Tuberc Lung Dis; 2003 Mar; 7(3):284-8. PubMed ID: 12661845 [TBL] [Abstract][Full Text] [Related]
11. Drug-resistant tuberculosis in Sierra Leone. Gibson J Tubercle; 1986 Jun; 67(2):119-24. PubMed ID: 3095965 [TBL] [Abstract][Full Text] [Related]
12. Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana. Addo KK; Addo SO; Mensah GI; Mosi L; Bonsu FA BMC Infect Dis; 2017 Dec; 17(1):743. PubMed ID: 29197331 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis. Kaushik A; Ammerman NC; Tasneen R; Story-Roller E; Dooley KE; Dorman SE; Nuermberger EL; Lamichhane G J Antimicrob Chemother; 2017 Aug; 72(8):2320-2325. PubMed ID: 28575382 [TBL] [Abstract][Full Text] [Related]
14. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece. Trakada G; Tsiamita M; Spiropoulos K Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340 [TBL] [Abstract][Full Text] [Related]
15. Sequencing of the entire rpob gene and characterization of mutations in isolates of Mycobacterium tuberculosis circulating in an endemic tuberculosis setting. Luna JF; Montero H; Sampieri CL; Muñiz-Salazar R; Zenteno-Cuevas R J Glob Antimicrob Resist; 2019 Dec; 19():98-103. PubMed ID: 30872039 [TBL] [Abstract][Full Text] [Related]
16. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Srivastava K; Das R; Jakhmola P; Gupta P; Chauhan DS; Sharma VD; Singh HB; Sachan AS; Katoch VM Indian J Med Res; 2004 Aug; 120(2):100-5. PubMed ID: 15347859 [TBL] [Abstract][Full Text] [Related]
17. Rifampicin: a first line tuberculostatic drug. A critical review and appraisal. Saerens EJ Acta Tuberc Pneumol Belg; 1972; 63(6):516-28. PubMed ID: 4206441 [No Abstract] [Full Text] [Related]
18. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406 [TBL] [Abstract][Full Text] [Related]
19. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231 [TBL] [Abstract][Full Text] [Related]
20. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. Dutta NK; Mazumdar K; Dastidar SG; Park JH Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]